A patient-derived bladder cancer cell line used as a model of low-invasive disease to study urothelial differentiation, tumour invasion, and bladder cancer progression. Only available through CancerTools. Save 30% on this cell line this autumn. Use code ACA26CELL at checkout.
| Inventor | Institute |
|---|---|
| Chris Marshall | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 153250 |
|---|---|
| Product description: | The RT112/84 cell line is derived from human bladder carcinoma. This cell line is a slow growing tumour which does not form colonies in soft agar. RT1112/84 cells requires 400 cells/dish to form colonies. RT112/84 is tumourigenic in nude mice. This cell line expresses high levels of E-cadherin, alpha-, beta-, and gamma-catenins. |
| Alternate name: | RT112-84; RT-112/84; RT11284 |
| Gender: | Female |
| Additional notes: | STR-PCR Data: Amelogenin: X CSF1PO: 10,11 D13S317: 13,14 D16S539: 11,13 D5S818: 10,13 D7S820: 11,12 THO1: 7 TPOX: 8,11 vWA: 14,17 |
| Cellosaurus ID: | CVCL_2714 |
| Disease: | Cancer |
| Cat. #: | 153250 |
|---|---|
| Provenance and Ownership: | The RT112/84 Cell Line is owned by Cancer Research UK. CancerTools supplies the RT112/84 Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing RT112/84 Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Bladder cancer |
| Organism: | Human |
| Tissue: | Bladder |
| Gender: | Female |
| Model: | Tumour line |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Human bladder carcinoma epithelial |
| Primary citation: | Marshall et al. 1977. J Natl Cancer Inst. 58(6):1743-51. PMID: 864752. |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | EMEM (EBSS) + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 10% Foetal Bovine Serum (FBS). |
| Subculture routine: | Split sub-confluent cultures (70-80%) seeding at 2-4×10,000 cells/cm² using 0.05% trypsin/EDTA; 5% CO₂; 37°C. Subculture weekly – cells are difficult to trypsinise, and should be kept sub-confluent. |
| References: |
Marshall et al. 1977. J Natl Cancer Inst. 58(6):1743-51. PMID: 864752. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.